Skip to main content

Secondary Vasculitis

  • Chapter
  • First Online:
Vasculitis in Clinical Practice

Abstract

Vasculitis often occurs as a primary event (de novo), but can occur on the background of a number of other diseases; in particular, it is associated with certain infections, drugs, and connective tissue diseases such as rheumatoid arthritis and SLE. It can also occur in association with some malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Watts RA, Mooney J, Lane SE, Scott DGI. Rheumatoid vasculitis – becoming extinct? Rheumatology. 2004;43:920-923.

    Article  PubMed  CAS  Google Scholar 

  2. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus associated polyarteritis nodosa. Clinical characteritistics, outcome and impact of treatment in 115 patients. Medicine (Baltimore) 2005;84:313-322.

    Google Scholar 

  3. Tatsis E, Reinhold-Keller E, Steindorf K, Feller AC, Gross WL. Wegener’s granulomatosis associated with renal cell carcinoma. Arthritis Rheum. 1999;42:751-756.

    Article  PubMed  CAS  Google Scholar 

  4. Stone JH, Holbrook JT, Marriott MA, et al. Solid malignancies among patients in the Wegener’s Granulomatosis Etanercept Trial. Arthritis Rheum. 2006;54:1608-1618.

    Article  PubMed  CAS  Google Scholar 

  5. Hamidou MA, Derenne S, Audrain MA, Berthelot JM, Boumalassa A, Grolleau JY. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. Rheumatology (Oxford). 2000;39:417-420.

    Article  CAS  Google Scholar 

  6. Knight A, Askling J, Granath F, Sparen P, Ekbom A. Urinary bladder cancer in Wegener’s granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis. 2004 Oct;63(10):1307-1311.

    Article  PubMed  CAS  Google Scholar 

  7. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43:405-413.

    Article  PubMed  CAS  Google Scholar 

  8. Wechsler ME, Finn D, Gunawardena D, et al. Churg–Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest. 2000;117:708-713.

    Article  PubMed  CAS  Google Scholar 

  9. Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984;76:377-384.

    Article  PubMed  CAS  Google Scholar 

  10. Townend JN, Emery P, Davies MK, Littler WA. Acute aortitis and aortic incompetence due to systemic rheumatological disorders. Int J Cardiol. 1991;33:253-258.

    Article  PubMed  CAS  Google Scholar 

  11. Somer T, Finegold SM. Clin Infect Dis. 1995;20:1010-1036.

    Article  PubMed  CAS  Google Scholar 

  12. Pagnoux C, Cohen P, Guillevin L. Vasculitis secondary to infections. Clin Exp Rheumatol. 2006;24(suppl 2):S71-S81.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Watts, R.A., Scott, D.G.I. (2010). Secondary Vasculitis. In: Watts, R., Scott, D. (eds) Vasculitis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84996-247-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-247-6_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-246-9

  • Online ISBN: 978-1-84996-247-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics